Registry name: Clinical Research Information Service (CRiS)
- CRiS is under the direction of the Korea Centers for Disease Control and Prevention (KCDC), receiving funding exclusively from South Korea’s Ministry of Health and Welfare (MOHW).
- In the first four years of operation, only 17.8 percent of clinical trials were registered before the first subject enrolled in the study.
- All processes for registering clinical trials in CRiS are in the Korean language, and a mastery of the language is needed to register trials in this system.
- CRiS recommends registering clinical trials before the first subject’s enrollment, but it does accept clinical trial registration when a study is ongoing or after it has completed.
- Registration of clinical trials is Korea is not yet legally required (as of January 2019).
- A full set of information explaining the data requirements for clinical trial registration with the system can be found here: https://cris.nih.go.kr/cris/en/images/explain_en.pdf
- To register clinical trials in South Korea, visit: http://cris.nih.go.kr/cris/inc/login.jsp
Related transparency research/articles:
- Review of the Registration in the Clinical Research Information Service
- Underregistration and Underreporting of Stem Cell Clinical Trials in Neurological Disorders
- Will Korea mandate advance registration of clinical trials by law?
- Need for Registration and Reporting of Acupuncture Trials in Parkinson’s Disease in Korea
TrialAssure® Registry can automate the disclosure of clinical trial results for the Clinical Research Information Service (CRiS) in South Korea. For questions or a free demo, fill out this form.